Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page
- Check2 days agoChange DetectedA new version of the clinical trial record was submitted on November 6, 2026, and posted on November 9, with a study-status update. The previous July 20 date was removed.SummaryDifference0.2%

- Check9 days agoChange DetectedA sitewide notice announces updates and FAQs related to NIH websites, including a terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.4%

- Check16 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check23 days agoChange DetectedA banner was added announcing NIH website changes and noting that some content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.4%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2. The study record history remains unchanged.SummaryDifference0.1%

- Check37 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, reflecting a minor site version update.SummaryDifference0.1%

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.